The association of body mass index with safety and effectiveness of first-line carboplatin-based chemotherapy in patients with metastatic non-small cell lung cancer von Kicken, M.P., Kilinc, H.D., Cramer-van der Welle, C.M., Houterman, S., van den Borne, B.E.E.M., Smit, A.A.J., van de Garde, E.M.W., Deenen, M.J.

Volltext